LOS ANGELES--(BUSINESS WIRE)--Puma Biotechnology, Inc. (NYSE: PBYI), a biopharmaceutical company,
announced that its drug candidate neratinib was highlighted in three
poster presentations at the American Association for Cancer Research
(AACR) Annual Meeting 2016. The AACR Annual Meeting was held at the
Ernest N. Morial Convention Center in New Orleans from April 16 to April
Abstract Number 298: Amplification of mutant ERBB2
drives resistance to themore...